Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabizon

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Cancer Research|November 1, 1982
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in miceA Gabizon, A Dagan, D Goren, et al.
Anti-Cancer Drugs|January 12, 2000
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsS Bandak, D Goren, A Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma modelA Cabanes, D Tzemach, D Goren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2007
Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticlesJ E Schroeder, I Shweky, H Shmeeda, et al.
Journal of Drug Targeting|January 1, 1996
Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclinesA Gabizon, M Chemla, D Tzemach, et al.
BMJ Oncology|January 31, 2025
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspectiveAlberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, et al.
Cancer Research|October 1, 1990
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studiesA Gabizon, D C Price, J Huberty, et al.
Advanced Drug Delivery Reviews|June 12, 2020
Translational considerations in nanomedicine: The oncology perspectiveAlberto A Gabizon, Rafael T M de Rosales, Ninh M La-Beck
Cancer Research|October 1, 1983
Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriersA Gabizon, D Goren, Z Fuks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pumpD Goren, A T Horowitz, D Tzemach, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Cancer Research|November 1, 1982
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in miceA Gabizon, A Dagan, D Goren, et al.
Anti-Cancer Drugs|January 12, 2000
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsS Bandak, D Goren, A Horowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma modelA Cabanes, D Tzemach, D Goren, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 12, 2007
Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticlesJ E Schroeder, I Shweky, H Shmeeda, et al.
Journal of Drug Targeting|January 1, 1996
Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclinesA Gabizon, M Chemla, D Tzemach, et al.
BMJ Oncology|January 31, 2025
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspectiveAlberto A Gabizon, Shira Gabizon-Peretz, Shadan Modaresahmadi, et al.
Cancer Research|October 1, 1990
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studiesA Gabizon, D C Price, J Huberty, et al.
Advanced Drug Delivery Reviews|June 12, 2020
Translational considerations in nanomedicine: The oncology perspectiveAlberto A Gabizon, Rafael T M de Rosales, Ninh M La-Beck
Cancer Research|October 1, 1983
Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriersA Gabizon, D Goren, Z Fuks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pumpD Goren, A T Horowitz, D Tzemach, et al.
Pageof 9